Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 522
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
for
Acute Lymphoblastic Leukemia, Obesity
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 18+
Code: NCT07228741
Phase2, Recruiting
Stakeholders of Rare Diseases Informing Values In Neuroethics
for
Rare Disorder, Disorder, Neurologic
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT07314736
Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Memphis TN, St Louis MO, Atlanta GA, Indianapolis IN,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase3, Recruiting
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
for
Refractory Solid Tumor, Hepatocellular Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 30
Code: NCT05468359
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
for
Medulloblastoma
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT07085325
Recruiting
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
for
Leukemia, Acute Myeloid Leukemia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 25
Code: NCT06810583
Phase1, Recruiting
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
for
Sickle Cell Disease
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 13+
Code: NCT04416178
Recruiting
Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Location: Memphis TN, Atlanta GA, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 18
Code: NCT06934967
Phase3, Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Memphis TN, Birmingham AL, St Louis MO, Indianapolis IN,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT07110246
Phase2, Recruiting
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
for
Sickle Cell Disease, Executive Dysfunction,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 8 - 17
Code: NCT07226219
Phase1, Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Memphis TN, Atlanta GA, Minneapolis MN,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT04901702
Phase1, Phase2, Recruiting
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
for
Neuroblastoma
Location: Memphis TN, Dallas TX, Fort Worth TX, Columbus OH,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Sex: All
Age: 1 - 31
Code: NCT06450041
Phase2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Memphis TN, Springfield MO, St Louis MO, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase2, Recruiting
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Location: Memphis TN, Little Rock AR, Nashville TN, Jackson MS,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
for
Neuroblastoma Recurrent
Location: Memphis TN, Philadelphia PA
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 30
Code: NCT07085338
Phase2, Recruiting
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease